| 产品编号 | CFN91038 | |
| CAS编号 | 1343403-10-0 | |
| 分子式 = 分子量 | C15H20O4 = 264.3 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Sesquiterpenoids | |
| 植物来源 | The roots of Inula helenium L. | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 1mg | QQ客服:1413575084 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 5mg | QQ客服:1413575084 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 10mg | QQ客服:1413575084 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 20mg | QQ客服:1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Epoxymicheliolide, a novelguaiane-type sesquiterpene lactone, inhibits NF‑κB/COX‑2 signaling pathways by targeting leucine 281 and leucine 25 in IKKβ in renal cell carcinoma, it may be a novel anticancer agent in the treatment of renal cell carcinoma. |
| Targets: | NF‑κB | COX‑2 |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.7836 mL | 18.9179 mL | 37.8358 mL | 75.6716 mL | 94.5895 mL |
| 5 mM | 0.7567 mL | 3.7836 mL | 7.5672 mL | 15.1343 mL | 18.9179 mL |
| 10 mM | 0.3784 mL | 1.8918 mL | 3.7836 mL | 7.5672 mL | 9.4589 mL |
| 50 mM | 0.0757 mL | 0.3784 mL | 0.7567 mL | 1.5134 mL | 1.8918 mL |
| 100 mM | 0.0378 mL | 0.1892 mL | 0.3784 mL | 0.7567 mL | 0.9459 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 1-2-(二甲基氨基)乙基-4-甲氧基-3-菲酚; Argentinine | CFN96081 | 16625-57-3 | C19H21NO2 = 295.4 | 5mg | QQ客服:215959384 |
| 辛夷脂素; Fargesin | CFN98174 | 31008-19-2 | C21H22O6 = 370.39 | 20mg | QQ客服:1413575084 |
| Pterolactone A; Pterolactone A | CFN96247 | 74730-10-2 | C15H16O4 = 260.3 | 5mg | QQ客服:1413575084 |
| 甘遂萜酯B; Kansuinine B | CFN92866 | 57685-46-8 | C38H42O14 = 722.7 | 5mg | QQ客服:3257982914 |